BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 37296188)

  • 1. Postprandial effect of gastrointestinal hormones and gastric activity in patients with irritable bowel syndrome.
    Furgała A; Ciesielczyk K; Przybylska-Feluś M; Jabłoński K; Gil K; Zwolińska-Wcisło M
    Sci Rep; 2023 Jun; 13(1):9420. PubMed ID: 37296188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of gut hormones with irritable bowel syndrome.
    Zhang H; Yan Y; Shi R; Lin Z; Wang M; Lin L
    Digestion; 2008; 78(2-3):72-6. PubMed ID: 18948690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autonomic nervous system activity in constipation-predominant irritable bowel syndrome patients.
    Mazur M; Furgała A; Jabłoński K; Mach T; Thor P
    Med Sci Monit; 2012 Aug; 18(8):CR493-499. PubMed ID: 22847198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proximal and distal gut hormone secretion in irritable bowel syndrome.
    Van Der Veek PP; Biemond I; Masclee AA
    Scand J Gastroenterol; 2006 Feb; 41(2):170-7. PubMed ID: 16484122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cholecystokinin on rectal motor and sensory function in patients with irritable bowel syndrome and healthy controls.
    van der Schaar PJ; van Hoboken E; Ludidi S; Masclee AA
    Colorectal Dis; 2013 Jan; 15(1):e29-34. PubMed ID: 23006632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
    Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
    J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chili on postprandial gastrointestinal symptoms in diarrhoea predominant irritable bowel syndrome: evidence for capsaicin-sensitive visceral nociception hypersensitivity.
    Gonlachanvit S; Mahayosnond A; Kullavanijaya P
    Neurogastroenterol Motil; 2009 Jan; 21(1):23-32. PubMed ID: 18647268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibited postprandial retrograde cyclic motor pattern in the distal colon of patients with diarrhea-predominant irritable bowel syndrome.
    Wiklendt L; Mohd Rosli R; Kumar R; Paskaranandavadivel N; Bampton PA; Maslen L; Costa M; Brookes SJ; O'Grady G; Dinning PG
    Am J Physiol Gastrointest Liver Physiol; 2023 Jul; 325(1):G62-G79. PubMed ID: 37162180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.
    Jacobsen SH; Olesen SC; Dirksen C; Jørgensen NB; Bojsen-Møller KN; Kielgast U; Worm D; Almdal T; Naver LS; Hvolris LE; Rehfeld JF; Wulff BS; Clausen TR; Hansen DL; Holst JJ; Madsbad S
    Obes Surg; 2012 Jul; 22(7):1084-96. PubMed ID: 22359255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome.
    Simrén M; Abrahamsson H; Björnsson ES
    Gut; 2001 Jan; 48(1):20-7. PubMed ID: 11115818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of gut hormones in irritable bowel syndrome].
    Morise K; Furusawa A; Yamamoto H; Saito H
    Nihon Rinsho; 1992 Nov; 50(11):2697-702. PubMed ID: 1287245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of serum gastric peptide ghrelin hormone level in irritable bowel syndrome at Zagazig University Hospitals.
    Monem SMA; Elbadrawy EG; Shalaby SM; Hendawy DM; Hassan SM; Almonem NA
    J Med Life; 2022 Dec; 15(12):1525-1531. PubMed ID: 36762339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Starch- and Sucrose-Reduced Diet in Irritable Bowel Syndrome Leads to Lower Circulating Levels of PAI-1 and Visfatin: A Randomized Controlled Study.
    Roth B; Myllyvainio J; D'Amato M; Larsson E; Ohlsson B
    Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are gut peptides responsible for the irritable bowel syndrome (IBS)?
    Sjölund K; Ekman R
    Scand J Gastroenterol Suppl; 1987; 130():15-20. PubMed ID: 3477012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GHSR-1 agonist sensitizes rat colonic intrinsic and extrinsic neurons to exendin-4: A role in the manifestation of postprandial gastrointestinal symptoms in irritable bowel syndrome?
    Buckley MM; O'Brien R; Buckley JM; O'Malley D
    Neurogastroenterol Motil; 2019 Oct; 31(10):e13684. PubMed ID: 31311066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.
    Konturek JW
    J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered vasoactive intestinal peptides expression in irritable bowel syndrome patients and rats with trinitrobenzene sulfonic acid-induced colitis.
    Del Valle-Pinero AY; Sherwin LB; Anderson EM; Caudle RM; Henderson WA
    World J Gastroenterol; 2015 Jan; 21(1):155-63. PubMed ID: 25574088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysfunction of the autonomic nervous system activity is responsible for gastric myoelectric disturbances in the irritable bowel syndrome patients.
    Mazur M; Furgała A; Jabłoński K; Madroszkiewicz D; Ciećko-Michalska I; Bugajski A; Thor PJ
    J Physiol Pharmacol; 2007 Aug; 58 Suppl 3():131-9. PubMed ID: 17901589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between preprandial and postprandial rectal sensory and motor abnormalities in IBS.
    Törnblom H; Van Oudenhove L; Tack J; Simrén M
    Gut; 2014 Sep; 63(9):1441-9. PubMed ID: 24142965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of irritable bowel syndrome: novel approaches to the pharmacology of gut motility.
    Scarpignato C; Pelosini I
    Can J Gastroenterol; 1999 Mar; 13 Suppl A():50A-65A. PubMed ID: 10202210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.